1. Home
  2. STNE vs GPCR Comparison

STNE vs GPCR Comparison

Compare STNE & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo StoneCo Ltd.

STNE

StoneCo Ltd.

HOLD

Current Price

$10.52

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$54.89

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
STNE
GPCR
Founded
2012
2016
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
2.8B
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
STNE
GPCR
Price
$10.52
$54.89
Analyst Decision
Buy
Strong Buy
Analyst Count
7
12
Target Price
$19.07
$103.17
AVG Volume (30 Days)
4.0M
934.0K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.07
N/A
Revenue Next Year
$6.05
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.45
$15.80
52 Week High
$19.95
$94.90

Technical Indicators

Market Signals
Indicator
STNE
GPCR
Relative Strength Index (RSI) 41.70 71.79
Support Level $10.44 $36.11
Resistance Level $11.71 $57.23
Average True Range (ATR) 0.43 2.78
MACD 0.01 0.89
Stochastic Oscillator 7.81 85.13

Price Performance

Historical Comparison
STNE
GPCR

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: